Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 10:11:1467234.
doi: 10.3389/fmed.2024.1467234. eCollection 2024.

Efficacy of vitamin D supplementation on depressive symptoms in older patients: a meta-analysis of randomized controlled trials

Affiliations

Efficacy of vitamin D supplementation on depressive symptoms in older patients: a meta-analysis of randomized controlled trials

Jiamin Fu et al. Front Med (Lausanne). .

Abstract

Background: The relationship between vitamin D and depression has garnered significant attention in recent years. However, the efficacy of vitamin D in ameliorating depression among specific subgroups of older patients remains controversial. This study aimed to assess the impact of vitamin D supplementation on depressive symptoms and the prevalence of depression in older adults. Additionally, the study sought to examine potential moderating factors, including differences among population subgroups and various supplementation strategies.

Methods: A systematic literature search was conducted in the databases PubMed, EMBASE, Web of Science, and the Cochrane Library up to March 2024. The RevMan 5.3 software was utilized to calculate the standardized mean difference (SMD) and to evaluate the quality of evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. The objective was to determine the efficacy of vitamin D supplementation in alleviating depressive symptoms or treating depression in older adults.

Results: This meta-analysis encompassed eleven studies, comprising a total of 21,561 participants. The findings did not indicate a statistically significant therapeutic benefit of vitamin D supplementation for depression in older patients [SMD: -0.10; 95% CI: (-1.19, 0.00); p = 0.05]. Subgroup analyses revealed that the efficacy of vitamin D intervention in geriatric depression correlated with several factors, including baseline serum 25(OH)D levels, the dosage of the intervention, gender, and the initial presence of depressive symptoms or a diagnosis of depression.

Conclusion: The current evidence is insufficient to conclusively establish the significant efficacy of vitamin D supplementation in alleviating depressive symptoms among older patients. Consequently, additional randomized controlled trials are warranted to further validate the relationship between vitamin D supplementation and depression in the older adults.

Keywords: depression; depressive symptoms; geriatrics; meta-analysis; therapeutic evaluation; vitamin D.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of the study selection process.
Figure 2
Figure 2
Quality assessment of final screening studies.
Figure 3
Figure 3
Forest plot of correlation between vitamin D supplementation intervention and depression scale scores compared with placebo.
Figure 4
Figure 4
Forest plot of correlation between vitamin D intervention and geriatric depression scale score in a population with different baseline vitamin D levels.
Figure 5
Figure 5
Forest plot of correlation between different doses of vitamin D supplementation. Interventions and depression scale scores.
Figure 6
Figure 6
Funnel plot of the effect of vitamin D on depression scores.

Similar articles

Cited by

References

    1. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, et al. . Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. (2013) 10:e1001547. doi: 10.1371/journal.pmed.1001547, PMID: - DOI - PMC - PubMed
    1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. (2006) 3:e442. doi: 10.1371/journal.pmed.0030442, PMID: - DOI - PMC - PubMed
    1. Leach LS. Review: major depression affects about 7% of adults aged 75 and above. Evid Based Ment Health. (2012) 15:64. doi: 10.1136/ebmental-2012-100694, PMID: - DOI - PubMed
    1. Luppa M, Sikorski C, Luck T, Ehreke L, Konnopka A, Wiese B, et al. . Age- and gender-specific prevalence of depression in latest-life--systematic review and meta-analysis. J Affect Disord. (2012) 136:212–21. doi: 10.1016/j.jad.2010.11.033 - DOI - PubMed
    1. Johnston KM, Powell LC, Anderson IM, Szabo S, Cline S. The burden of treatment-resistant depression: a systematic review of the economic and quality of life literature. J Affect Disord. (2019) 242:195–210. doi: 10.1016/j.jad.2018.06.045, PMID: - DOI - PubMed

Publication types

LinkOut - more resources